The Role of Beta Blockers in Treating Hypertensive Patients | Zendy

Sang Yup Lim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Role of Beta Blockers in Treating Hypertensive Patients

Author(s) -

Sang Yup Lim

Publication year - 2009

Publication title -

chonnam medical journal

Language(s) - English

Resource type - Journals

ISSN - 0377-9564

DOI - 10.4068/cmj.2009.45.2.75

Subject(s) - medicine , nebivolol , carvedilol , beta (programming language) , tolerability , atenolol , pharmacology , adrenergic beta antagonists , beta blocker , blood pressure , cardiology , adverse effect , heart failure , propranolol , computer science , programming language

Beta-blockers have been used to treat hypertension for many years. Although beta-blockers can lower blood pressure, current data concerning the efficacy of these drugs have been disappointing, and the value of these drugs for patients without a compelling indication has been questioned. The early beta-blockers had significant pharmacologic disadvantages; however, new-generation beta-blockers have better pharmacologic profiles. The efficacy and tolerability of the most recently developed vasodilating beta-blockers (carvedilol and nebivolol) are currently being evaluated. Further investigation of these new beta-blockers is needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research